Activity of dermaseptin K4-S4 against foodborne pathogens

Peptides

Volumn 24, Issue 11, 2003, Pages 1815-1821

  Yaron, Sima ^a   Rydlo, Tali ^a   Shachar, Dina ^a   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antimicrobial peptides; Food preservation; Foodborn pathogens

Indexed keywords

ALANYLLEUCYLTRYPTOPHYLLYSYLTHREONYLLEUCYLLEUCYLLYSYLLYSYLVALYLLEUCYLLYSYLAL ANYLALANYLALANYLLYSYLALANYLALANYLLEUCYLASPARAGINYLALANYLVALYLLEUCYLVALYLGLYCYLAL ANYLASPARAGINYLALANINE; ANTIINFECTIVE AGENT; DERMASEPTIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; AMPHIBIAN PROTEIN; ANTIMICROBIAL CATIONIC PEPTIDE; DERMASEPTIN 4 PROTEIN, PHYLLOMEDUSA; INORGANIC SALT;

ANTIBACTERIAL ACTIVITY; APPLE JUICE; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; COMMERCIAL PHENOMENA; CULTURE MEDIUM; DRUG ACTIVITY; ESCHERICHIA COLI; FOOD; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; PH; PRIORITY JOURNAL; TEMPERATURE; AMINO ACID SUBSTITUTION; BACTERIAL INFECTION; BACTERIUM; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; FOOD CONTROL; GROWTH, DEVELOPMENT AND AGING; LISTERIA; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SALMONELLA ENTERICA;

ESCHERICHIA COLI; MALUS X DOMESTICA;

AMINO ACID SUBSTITUTION; AMPHIBIAN PROTEINS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; FOOD MICROBIOLOGY; HYDROGEN-ION CONCENTRATION; KINETICS; LISTERIA; MICROBIAL SENSITIVITY TESTS; SALMONELLA ENTERICA; SALTS; TEMPERATURE;

EID: 1042290505     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.09.016     Document Type: Article

References (42)

1. Andreu D., Rivas L. Animal antimicrobial peptides: an overview. Biopolymers. 47:1998;415-433.
2. Annamalai T., Venkitanarayanan K.S., Hoagland T.A., Khan M.I. Inactivation of Escherichia coli O157: H7 and Listeria monocytogenes by PR-26, a synthetic antibacterial peptide. J. Food Prot. 64:2001;1929-1934.
3. Belaid A., Aouni M., Khelifa R., Trabelsi A., Jemmali M., Hani K. In-vitro antiviral activity of dermaseptins against herpes simplex virus type 1. J. Med. Virol. 66:2002;229-234.
4. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:1995;61-92.
5. Brand G.D., Leite J.R., Silva L.P., Albuquerque S., Prates M.V., Azevedo R.B.et al. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J. Biol. Chem. 277:2002;49332-49340.
6. Charpentier S., Amiche M., Mester J., Vouille V., le Caer J.P., Nicolas P.et al. Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics. J. Biol. Chem. 273:1998;14690-14697.
7. Coote P.J., Holyoak C.D., Bracey D., Ferdinando D.P., Pearce J.A. Inhibitory action of the amphibian skin peptided dermaseptin S3 on S. cerevisiae. Antimicrob. Agents Chemother. 42:1998;2160-2170.
8. Cudic M., Bulet P., Hoffmann R., Craik D.J., Otvos L. Jr. Chemical synthesis, antibacterial activity and conformation of diptericin, an 82-mer peptide originally isolated from insects. Eur. J. Biochem. 266:1999;549-558.
9. Cudic M., Condie B.A., Weiner D.J., Lysenko E.S., Xiang Z.Q., Insug O.et al. Development of novel antibacterial peptides that kill resistant isolates. Peptides. 23:2002;2071-2083.
10. Dagan A., Efron L., Gaidukov L., Mor A., Ginsburg H. In-vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 46:2002;1059-1066.
11. de-Lucca A.J., Bland J.M., Jacks T.J., Grimm C., Walsh T.J. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin S1. Med. Mycol. 36:1998;291-298.
12. Efron L., Dagan A., Gaidukov L., Ginsburg H., Mor A. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J. Biol. Chem. 277:2002;24067-24072.
13. Epand M.E., Shai Y., Segrest J.P., Anantharamaiah G.M. Mechanisms for the modulation of membrane bilayer properties by amphipathic helical peptides. Biopolymers. 37:1995;319-338.
14. Feder R., Dagan A., Mor A. SAR study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275:2000;4230-4238.
15. Feder R., Nehushtai R., Mor A. Affinity deriven molecular transfer from erythrocyte membrane to target cells. Peptides. 22:2001;1683-1690.
16. Food and Drug Administration, 1988. Nisin preparation: affirmation of GRAS status as a direct human food ingredient. Fed Regist 53:11247.
17. Ghosh J.K., Shaool D., Guillaud P., Ciceron L., Mazier D., Kustanovich I.et al. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparium and the underlying molecular basis. J. Biol. Chem. 272:1997;31609-31616.
18. Hancock R.E.W. Peptide antibiotics. Lancet. 349:1997;418-422.
19. Hancock R.E.W., Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:1998;82-90.
20. Hernandez C., Mor A., Dagger F., Nicolas P., Hernandez A., Benedetti E.L.et al. Functional and structural damages in Leishmania mexicana exposed to the cationic peptide dermaseptin. Eur. J. Cell Biol. 59:1992;414-424.
21. Jouenne T., Mor A., Bonato H., Junter G.A. Antibacterial activity of synthetic dermaseptins against growing and non-growing E. coli cultures. J. Antimicrob. Chemother. 42:1998;87-90.
22. Krugliak M., Feder R., Zolotarev V.Y., Gaidukov L., Dagan A., Ginsburg H.et al. Antimalarial activity of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 44:2000;2442-2451.
23. Kustanovich I., Shalev D.E., Mikhlin M., Gaidukov L., Mor A. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277(19):2002;16941-16951.
24. Maisnier-Patin S.E., Forni E., Richard J. Purification, partial characterization and mode of action of enterococcin EFS2, an antilisterial bacteriocin produced by a strain of Enterococcus faecalis isolated from cheese. Int. J. Food Microbiol. 30:1996;255-270.
25. Mendoza F., Maqueda M., Galvez A., Martinez-Bueno M., Valdivia E. Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes. Appl. Environ. Microbiol. 65:1999;618-625.
26. Meng J, Doyle MP, Zhao T. Enterohemorrhagic Escherichia coli. In: Doyle MP, Beuchat LR, Montville TJ, editors. Food microbiology fundamentals and frontiers. 2nd ed. Washington, DC: ASM Press; 2001.
27. Mor A. Antimicrobial peptides. The Kirk-Othmer encyclopedia of chemical technology, 2001. http://www3.interscience.wiley.com:8095/articles/peptwise.a01/ frame.html .
28. Mor A. Peptide-based antibiotics: a potential answer to raging antimicrobial resistance. Drug Deliv. Res. 50:2000;440-447.
29. Mor A., Amiche M., Nicolas P. Structure, synthesis and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin. Biochemistry. 33:1994;6642-6650.
30. Mor A., Hani K., Nicolas P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 269:1994;31635-31641.
31. Mor A., Nguyen V.H., Delfour A., Migliore S.D., Nicolas P. Isolation, amino acid sequence and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry. 3:1991;8824-8830.
32. Mor A., Nicolas P. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem. 219:1994;145-154.
33. Mor A., Nicolas P. The NH2-terminal helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J. Biol. Chem. 269:1994;1934-1939.
34. Navon-Venezia S., Feder R., Gaidukov L., Carmeli Y., Mor A. Antibacterial properties of dermaseptin S4 derivatives with in-vivo activity. Antimicrob. Agents Chemother. 46:2002;689-694.
35. Nicolas P., Mor A. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 4:1995;277-304.
36. Riley M.A., Wertz J.E. Bacteriocins: evolution, ecology, and application. Annu. Rev. Microbiol. 56:2002;117-137.
37. Sahl H.G., Bierbaum G. Lantibiotics: biosynthesis and biological activities of uniquel modified peptides from Gram-positive bacteria. Annu. Rev. Microbiol. 52:1998;41-79.
38. Simmaco M., Mignogna G., Barra D. Antimicrobial peptides from amphibian skin: what do the tell us. Biopolymers. 47:1998;435-450.
39. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers. 66:2002;236-248.
40. Tossi A., Sandri L., Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers. 55:2000;4-30.
41. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395.
42. Zasloff M. Innate immunity, antimicrobial peptides and protection of the oral cavity. Lancet. 360:2002;1116.